Skip to content

International Conference on Drug Discovery and Translational Medicine 2025 (ICDDTM'25)

Fostering Global Interdisciplinary Collaboration for Sustainable Innovation in Drug Discovery and Translational Medicine

Venue: Hospital Sultan Abdul Aziz Shah (HSAAS), Universiti Putra Malaysia (UPM), Serdang, Selangor
Date: 24-25 November (Pre-Conference Workshops) & 26-27 November 2025 (ICDDTM'25 Conference)
Menu
  • Home
    • Welcome and Selamat Datang
    • Committee Members
    • Gallery
    • The Venue
      • Nearby Hotels
  • Programme Schedule
    • Programme Schedule
    • Why You Should Attend
    • Plenary & Invited Speakers
    • Pre-Conference Workshops
      • Pharmacometrics
      • Conducting Clinical Trials
      • AI and Machine Learning in Drug Discovery: From Target Identification to Personalised Medicine
      • Network Pharmacology
      • All Topics
    • Special Forums
    • ICDDTM’25 Posters
  • Register
  • Submit Abstract
    • Author’s Guideline
      For Abstract
      • General Guidelines For Oral Presentation
      • General Guidelines For Poster Presentation
    • Awards
      • Travel Awards
  • Contact
  • F.A.Q.
  • Be A Sponsor
Menu

Conducting Clinical Trials



This workshop provides a focused and practical overview of essential elements required for initiating clinical trials. The session will cover three key areas:

a) Preclinical data requirements for clinical trial applications,
b) The different categories of clinical trials, and
c) Common myths and pitfalls that may hinder trial integrity and execution.

Participants will gain practical insights into study planning, and real-world challenges in clinical trial implementation. This workshop is ideal for investigators, sponsors, and research teams aiming to enhance their trial readiness and conduct high-quality research.

SPEAKER

Mr. Chew Chun Keat

Mr Chew Chun Keat (CK) is the Technical Head at the Centre for Clinical Trial, Institute for Clinical Research, National Institutes of Health, and a Fellow at the International Vaccine Institute. He played a key role in establishing one of Malaysia’s two NPRA-accredited First-in-Human (FIH) trial centers at Hospital Ampang. The centre has since led and conducted numerous trials, including bioavailability, bioequivalence, vaccine efficacy, drug delivery systems, and drug-drug/food-drug interaction studies.

CK is a board member of the Medical Research and Ethics Committee (MREC) under the Ministry of Health. He also contributed to the enhancement of pharmacovigilance oversight in clinical trials through the development of an online platform for reporting Serious Adverse Events (SAE) and Suspected Unexpected Serious Adverse Reactions (SUSAR).

He actively supports the World Health Organization (WHO) in alignment with the World Health Assembly’s direction on strengthening national and regional clinical trial ecosystems. He has served on expert panels and working groups involved in the development of key national guidelines, including the Malaysian Guideline for Phase 1 Unit Inspection & Accreditation Programme, Malaysian Phase 1 Clinical Trial Guideline, and A Guide to Conducting Clinical Trials in Malaysia.



Click here to view all the other Pre-Conference Workshops >>

Venue:
Hospital Sultan Abdul Aziz Shah (HSAAS), Universiti Putra Malaysia (UPM), Serdang, Selangor

ICDDTM'25 Flyer

Right click and Save As ICDDTM'25 Poster

All abstracts will be published in an indexed (Scopus or WoS) journal

Disclaimer

The information on this website is regularly updated to reflect the latest developments. While we strive for accuracy, details may change without prior notice.

All claims on the advertisements stated in this website are those of the vendors and journals and do not reflect the official position or endorsement from the organisers of ICDDTM'25. The organisers of ICDDTM'25 acknowledge the importance of having research data to substantiate all advertisement claims, and the research or citation is to be made available on the vendors’ and journals’ website or, where proprietary interests exist, be made available upon request.

Flag Counter
(Dr. D Y. Patil Dnyan Prasad University, Pune, India)
(Nirma University, India)
(University of Asia Pacific, Bangladesh)
(University of Gajah Mada, Indonesia)
(Birla Institute of Technology Mesra, India)
(The Halifax Institute, Canada)
(Jashore University of Science and Technology, Bangladesh)
(Yantai Affiliated Hospital of Binzhou Medical University, China)
(Universitas Andalas, Padang, Indonesia)
(Dhaka University, Bangladesh)
© 2025 International Conference on Drug Discovery and Translational Medicine 2025 (ICDDTM'25) | Organised by Malaysian Association for Cancer Research